These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 30440261)

  • 1. Imaging of IR700DX Labeled Mouse Breast Tumor Using a Custom Angle-Selective Fluorescence Contact Imaging System.
    Papageorgiou EP; Giverts S; Zhang H; Park C; Boser BE; Anwar M
    Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():1-4. PubMed ID: 30440261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-time, intraoperative detection of residual breast cancer in lumpectomy cavity walls using a novel cathepsin-activated fluorescent imaging system.
    Smith BL; Gadd MA; Lanahan CR; Rai U; Tang R; Rice-Stitt T; Merrill AL; Strasfeld DB; Ferrer JM; Brachtel EF; Specht MC
    Breast Cancer Res Treat; 2018 Sep; 171(2):413-420. PubMed ID: 29948401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual in vivo photoacoustic and fluorescence imaging of HER2 expression in breast tumors for diagnosis, margin assessment, and surgical guidance.
    Maeda A; Bu J; Chen J; Zheng G; DaCosta RS
    Mol Imaging; 2014; 13():. PubMed ID: 25430722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence Lifetime-Based Tumor Contrast Enhancement Using an EGFR Antibody-Labeled Near-Infrared Fluorophore.
    Pal R; Kang H; Choi HS; Kumar ATN
    Clin Cancer Res; 2019 Nov; 25(22):6653-6661. PubMed ID: 31481509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.
    Sampath L; Kwon S; Ke S; Wang W; Schiff R; Mawad ME; Sevick-Muraca EM
    J Nucl Med; 2007 Sep; 48(9):1501-10. PubMed ID: 17785729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paired Agent Fluorescence Imaging of Cancer in a Living Mouse Using Preassembled Squaraine Molecular Probes with Emission Wavelengths of 690 and 830 nm.
    Schreiber CL; Zhai C; Dempsey JM; McGarraugh HH; Matthews BP; Christmann CR; Smith BD
    Bioconjug Chem; 2020 Feb; 31(2):214-223. PubMed ID: 31756298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
    Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
    Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angle-insensitive amorphous silicon optical filter for fluorescence contact imaging.
    Papageorgiou EP; Zhang H; Boser BE; Park C; Anwar M
    Opt Lett; 2018 Feb; 43(3):354-357. PubMed ID: 29400857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chip-Scale Angle-Selective Imager for In Vivo Microscopic Cancer Detection.
    Papageorgiou EP; Boser BE; Anwar M
    IEEE Trans Biomed Circuits Syst; 2020 Feb; 14(1):91-103. PubMed ID: 31831434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preclinical application of MR and fluorescent dual-modality imaging combined with photothermal therapy in HER-2 positive breast cancer].
    Luo XJ; Li J; Zhou CW
    Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):587-593. PubMed ID: 30139028
    [No Abstract]   [Full Text] [Related]  

  • 11. Cerenkov-Activated Sticky Tag for In Vivo Fluorescence Imaging.
    Das S; Haedicke K; Grimm J
    J Nucl Med; 2018 Jan; 59(1):58-65. PubMed ID: 28912146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodal image-guided surgery of HER2-positive breast cancer using [
    Deken MM; Bos DL; Tummers WSFJ; March TL; van de Velde CJH; Rijpkema M; Vahrmeijer AL
    EJNMMI Res; 2019 Nov; 9(1):98. PubMed ID: 31754913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theranostic imaging of liver cancer using targeted optical/MRI dual-modal probes.
    Chen Q; Shang W; Zeng C; Wang K; Liang X; Chi C; Liang X; Yang J; Fang C; Tian J
    Oncotarget; 2017 May; 8(20):32741-32751. PubMed ID: 28416757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point-of-care Ratiometric Fluorescence Imaging of Tissue for the Diagnosis of Ovarian Cancer.
    Zhou X; Liu Y; Liu Q; Yan L; Xue M; Yuan W; Shi M; Feng W; Xu C; Li F
    Theranostics; 2019; 9(16):4597-4607. PubMed ID: 31367243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore.
    Lwin TM; Murakami T; Miyake K; Yazaki PJ; Shivley JE; Hoffman RM; Bouvet M
    Ann Surg Oncol; 2018 Apr; 25(4):1079-1085. PubMed ID: 29372363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescent Image-Guided Surgery with an Anti-Prostate Stem Cell Antigen (PSCA) Diabody Enables Targeted Resection of Mouse Prostate Cancer Xenografts in Real Time.
    Sonn GA; Behesnilian AS; Jiang ZK; Zettlitz KA; Lepin EJ; Bentolila LA; Knowles SM; Lawrence D; Wu AM; Reiter RE
    Clin Cancer Res; 2016 Mar; 22(6):1403-12. PubMed ID: 26490315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging.
    Hekman MCH; Boerman OC; Bos DL; Massuger LFAG; Weil S; Grasso L; Rybinski KA; Oosterwijk E; Mulders PFA; Rijpkema M
    Mol Pharm; 2017 Oct; 14(10):3457-3463. PubMed ID: 28826214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of antibody fragment properties for near-infrared fluorescence imaging of HER3-positive cancer xenografts.
    El-Sayed A; Bernhard W; Barreto K; Gonzalez C; Hill W; Pastushok L; Fonge H; Geyer CR
    Theranostics; 2018; 8(17):4856-4869. PubMed ID: 30279742
    [No Abstract]   [Full Text] [Related]  

  • 19. ICG fluorescence imaging as a new tool for optimization of pathological evaluation in breast cancer tumors after neoadjuvant chemotherapy.
    Veys I; Pop CF; Barbieux R; Moreau M; Noterman D; De Neubourg F; Nogaret JM; Liberale G; Larsimont D; Bourgeois P
    PLoS One; 2018; 13(5):e0197857. PubMed ID: 29799849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic fluorescent imaging with the activatable probe, γ-glutamyl hydroxymethyl rhodamine green in the detection of peritoneal cancer metastases: Overcoming the problem of dilution when using a sprayable optical probe.
    Nakamura Y; Harada T; Nagaya T; Sato K; Okuyama S; Choyke PL; Kobayashi H
    Oncotarget; 2016 Aug; 7(32):51124-51137. PubMed ID: 27286461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.